ArticleOncotarget2020

miR-708-5p enhances erlotinib/paclitaxel efficacy and overcomes chemoresistance in lung cancer cells.

Nicholas J Monteleone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.